|
|
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Raouf Ben Abdelali
,
Vahid Asnafi
,
Thibaut Leguay
,
Nicolas Boissel
,
Agnès Buzyn
et al.
Journal articles
hal-00777203v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study
Mathilde Hunault-Berger
,
Thibaut Leguay
,
Françoise Huguet
,
Stéphane Leprêtre
,
Eric Deconinck
et al.
Journal articles
hal-01237093v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Sophie Langner-Lemercier
,
Caroline Houillier
,
Carole Soussain
,
Hervé Ghesquières
,
Olivier Chinot
et al.
Journal articles
hal-01290413v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.
Benoît Bareau
,
Jérôme Rey
,
Mohamed Hamidou
,
Jean Donadieu
,
Jeff Morcet
et al.
Journal articles
hal-00744223v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience
Marie-Anne Couturier
,
Françoise Huguet
,
Patrice Chevallier
,
Felipe Suarez
,
Xavier Thomas
et al.
Journal articles
hal-01231425v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
Mathilde Hunault-Berger
,
Thibaut Leguay
,
Xavier Thomas
,
Ollivier Legrand
,
Françoise Huguet
et al.
Journal articles
hal-00821138v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors. A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire
Aurelie Ravinet
,
Aurélie Cabrespine
,
Gérard Socie
,
Noel Milpied
,
Ibrahim Yakoub Agha
et al.
Journal articles
hal-01231422v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|